Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 165 | 1.090 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1108 | 0.960 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 109 | 0.810 |
Why?
|
| Brain Mapping | 6 | 2021 | 149 | 0.780 |
Why?
|
| Blood Glucose | 2 | 2020 | 108 | 0.780 |
Why?
|
| Biomarkers | 3 | 2020 | 561 | 0.680 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.650 |
Why?
|
| Headache | 1 | 2019 | 38 | 0.630 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.610 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 17 | 0.600 |
Why?
|
| Lymphocytes | 1 | 2018 | 59 | 0.590 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.540 |
Why?
|
| Sclerosis | 1 | 2017 | 69 | 0.530 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 30 | 0.530 |
Why?
|
| Temporal Lobe | 1 | 2017 | 90 | 0.520 |
Why?
|
| Thalamus | 4 | 2021 | 15 | 0.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 95 | 0.490 |
Why?
|
| Image Enhancement | 2 | 2020 | 49 | 0.470 |
Why?
|
| Middle Aged | 22 | 2021 | 9068 | 0.470 |
Why?
|
| Adult | 22 | 2021 | 7945 | 0.470 |
Why?
|
| Humans | 43 | 2022 | 27307 | 0.470 |
Why?
|
| Female | 27 | 2021 | 15334 | 0.460 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 61 | 0.430 |
Why?
|
| Male | 27 | 2021 | 14887 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1648 | 0.420 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 64 | 0.380 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 83 | 0.360 |
Why?
|
| Brain Ischemia | 2 | 2021 | 63 | 0.330 |
Why?
|
| Aged | 14 | 2021 | 9120 | 0.320 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.310 |
Why?
|
| Motor Cortex | 1 | 2009 | 17 | 0.310 |
Why?
|
| Brain Diseases | 1 | 2009 | 64 | 0.300 |
Why?
|
| Young Adult | 6 | 2021 | 2032 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 125 | 0.290 |
Why?
|
| Graft Rejection | 2 | 2018 | 69 | 0.280 |
Why?
|
| Contrast Media | 3 | 2020 | 64 | 0.270 |
Why?
|
| Liver Transplantation | 2 | 2018 | 92 | 0.260 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 903 | 0.260 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.250 |
Why?
|
| Case-Control Studies | 4 | 2021 | 589 | 0.240 |
Why?
|
| Risk Factors | 7 | 2021 | 2335 | 0.240 |
Why?
|
| Language | 1 | 2005 | 63 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 118 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 930 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 94 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 31 | 0.200 |
Why?
|
| Turkey | 2 | 2018 | 6 | 0.190 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.180 |
Why?
|
| Encephalocele | 1 | 2021 | 26 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 39 | 0.180 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3551 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 47 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 87 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 71 | 0.170 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.170 |
Why?
|
| Glioma | 1 | 2021 | 24 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 40 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 46 | 0.170 |
Why?
|
| Facial Nerve | 1 | 2020 | 13 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 79 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2020 | 17 | 0.170 |
Why?
|
| Dissection | 1 | 2020 | 25 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 30 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 24 | 0.170 |
Why?
|
| Gray Matter | 1 | 2021 | 51 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 152 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 141 | 0.170 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 8 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 31 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 137 | 0.160 |
Why?
|
| Fasting | 1 | 2019 | 21 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 9 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 18 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 180 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 103 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 154 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 10 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 113 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 32 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 14 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 117 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 17 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 6 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 8 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 303 | 0.150 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 48 | 0.150 |
Why?
|
| Stomach | 1 | 2018 | 14 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 18 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 28 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 33 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 19 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 43 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 64 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 5 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 40 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 10 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 13 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 2185 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 44 | 0.150 |
Why?
|
| Child Development | 1 | 2019 | 69 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 72 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 13 | 0.140 |
Why?
|
| Spinal Diseases | 1 | 2019 | 113 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 132 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 339 | 0.140 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 164 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 218 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 7 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 14 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 667 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 29 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 12 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 32 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 44 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2017 | 62 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 486 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 270 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 201 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 288 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1792 | 0.120 |
Why?
|
| Child | 3 | 2021 | 1269 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 269 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 50 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 16 | 0.110 |
Why?
|
| Corpus Callosum | 2 | 2019 | 13 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4841 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 464 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 197 | 0.100 |
Why?
|
| Parkinson Disease | 2 | 2018 | 671 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 808 | 0.090 |
Why?
|
| Time Factors | 3 | 2020 | 1444 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1555 | 0.080 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1807 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 45 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 478 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 350 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 38 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 3 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 4 | 0.080 |
Why?
|
| Reference Values | 1 | 2009 | 185 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 315 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 5 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 11 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 415 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 97 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 631 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 7 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 675 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 344 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2006 | 63 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2019 | 462 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1380 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 18 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 82 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 48 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 624 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 9 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3540 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 8 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 5 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 29 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 458 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 28 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 39 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 42 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 104 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 43 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 469 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 6 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 14 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 12 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 20 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 64 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 148 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 141 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 32 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 87 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 58 | 0.040 |
Why?
|
| Thyroidectomy | 1 | 2017 | 19 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 130 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 183 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 121 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 517 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 162 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 562 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 321 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 9 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 12 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 8 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 380 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 324 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 4 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 10 | 0.030 |
Why?
|
| United States | 1 | 2019 | 2078 | 0.020 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 10 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 13 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 54 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 189 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 340 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 5 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 12 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 54 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 93 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 54 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 72 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 131 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 208 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 660 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 5 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 34 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 64 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 226 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 551 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3681 | 0.010 |
Why?
|